Abstract
No public abstract is available from the verified source records.
Roman Gulati, Ruth Etzioni
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Stockholm3 versus prostate-specific antigen in prostate cancer screening: 9-year outcomes demonstrating improved detection of aggressive cancers and reduced overdiagnosis from the STHLM3 trial
10.1016/j.eururo.2025.10.001 · 2026
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
10.1016/s1470-2045(15)00361-7 · 2015
Overdiagnosis and overtreatment of prostate cancer
10.1016/j.eururo.2013.12.062 · 2014
Biomarker: predictive or prognostic?
10.1200/jco.2015.63.3651 · 2015
No additional external references are available.